Polymorphism rs11465553 in the Interleukin-17F Gene in Serbian Patients with Psoriasis and Healthy Controls

1. Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol 2012;7:385-422.10.1146/annurev-pathol-011811-13244822054142Search in Google Scholar

2. Gudjonsson JE, Karason A, Antonsdottir AA, Runarsdottir EH, Gulcher JR, Stefansson K, et al. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 2002;118:362-5.10.1046/j.0022-202x.2001.01656.x11841557Search in Google Scholar

3. Naldi L. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passe? Facts and controversies. Clin Dermatol 2010;28:67-72.10.1016/j.clindermatol.2009.03.00120082954Search in Google Scholar

4. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005;210:194-9.10.1159/00008350915785046Search in Google Scholar

5. Ariza ME, Williams MV, Wong HK. Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application. Clin Immunol 2013;146:131-9.10.1016/j.clim.2012.12.00423314273Search in Google Scholar

6. Laggner U, Di Meglio P, Perera GK, Hundhausen C, Lacy KE, Ali N, et al. Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 2011;187:2783-93.10.4049/jimmunol.1100804318762121813772Search in Google Scholar

7. Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 2006;117:795-801.10.1016/j.jaci.2005.12.134616630936Search in Google Scholar

8. Watanabe H, Kawaguchi M, Fujishima S, Ogura M, Matsukura S, Takeuchi H, et al. Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. J Invest Dermatol 2009;129:650-6.10.1038/jid.2008.29418830271Search in Google Scholar

9. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011;187:490-500.10.4049/jimmunol.1100123311976421606249Search in Google Scholar

10. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 2008;28:44-9.10.1007/s10875-007-9125-817828618Search in Google Scholar

11. Shibata S, Saeki H, Tsunemi Y, Kato T, Nakamura K, Kakinuma T, et al. IL-17F single nucleotide polymorphism is not associated with psoriasis vulgaris or atopic dermatitis in the Japanese population. J Dermatol Sci 2009;53:163-5.10.1016/j.jdermsci.2008.09.00319019635Search in Google Scholar

12. Bazzi MD, Sultan MA, Al Tassan N, Alanazi M, Al-Amri A, Al-Hajjaj MS, et al. Interleukin 17A and F and asthma in Saudi Arabia: gene polymorphisms and protein levels. J Investig Allergol Clin Immunol 2011;21:551-5.Search in Google Scholar

13. Jang WC, Nam YH, Ahn YC, Lee SH, Park SH, Choe JY, et al. Interleukin-17F gene polymorphisms in Korean patients with Behcet's disease. Rheumatol Int 2008;29:173-8.10.1007/s00296-008-0664-y18769923Search in Google Scholar